PubMed Health⌕ Search

PubMed · 7879390

[Video-assisted thoracic surgery].

Abstract

Over the past two to three years video-assisted thoracic surgery has opened up new possibilities in diagnostic and therapeutic procedures. It is viewed as a sparing and quick alternative to thoracotomy and open operation for a number of indications including the treatment of pneumothorax, obtaining biopsies of undiagnosed diffuse or nodulary lung disease, as well as extirpation of peripheral pulmonary lesions. In oncological thoracic surgery it still remains to be verified whether the criteria of radicality are fulfilled by this new technique. Extipation of circumscribed, extrapulmonary benign tumours and cysts within the thoracic cavity will soon be routine procedures. The advantages lie in the minimally traumatizing surgical technique; as a result of avoiding thoracotomy postoperative pulmonary function is less restricted, there is less pain, earlier mobilization is possible and the period of hospitalization is reduced. In the majority of procedures the operative time is reduced as compared with open surgery. Our experiences in this field with 370 patients are briefly reported. Disadvantages are the loss of the possibility to palpate the lung and the thoracic cavity. The costs of employing this technique is discussed. Video-assisted thoracic surgery has a promising future; it is estimated that 20% to 30% of all thoracic interventions will be performed by this technique.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Eckersberger. 1995. [Video-assisted thoracic surgery].. https://pubmed.ncbi.nlm.nih.gov/7879390/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗